Research study Program year 2020 Source: CMS Open Payments

Nthimcat-X002

Research payments

$720,659

373 payments

Through program year 2020, $720,659 in research payments was reported against Nthimcat-X002, across 373 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$221,087	90
2019	Research	$499,572	283

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $720,659 373 payments

Who received the money Research payments · program years 2019–2020

Pulmonary Research of Abingdon Organisation paid for research $135,247 44 payments
Palmtree Clinical Research INC Organisation paid for research $78,935 34 payments
Center For Clinical Research Organisation paid for research $55,729 29 payments
Square One Clinical Research Organisation paid for research $53,791 26 payments
American Health Research Organisation paid for research $49,880 24 payments
Hackensack Meridian Health Organisation paid for research $26,121 5 payments
Clinical Research Of West Florida Organisation paid for research $25,076 14 payments
Wenatchee Valley Hospital Organisation paid for research $24,862 19 payments
The Corvallis Clinic Organisation paid for research $24,285 11 payments
Clinical Research Advantage INC-Tempe-U Organisation paid for research $23,708 20 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.